ECONOMIC COST, DIAGNOSTIC AND PROGNOSTIC MARKERS IN IATROGENIC LUMBAR SPONDYLODISCITIS

dc.contributor.authorYüksel, Ulaş
dc.contributor.authorÖğden, Mustafa
dc.contributor.authorAkkaya, Süleyman
dc.contributor.authorKısa, Üçler
dc.contributor.authorBakar, Bülent
dc.contributor.authorÖzveren, Mehmet Faik
dc.date.accessioned2025-01-21T16:19:27Z
dc.date.available2025-01-21T16:19:27Z
dc.date.issued2020
dc.departmentKırıkkale Üniversitesi
dc.description.abstractObjective: In this study, the economic cost, diagnostic andprognostic laboratory markers of lumbar spondylodiscitis, whichemerged as a complication after surgical intervention in thelumbar region, were investigated.Material and Methods: Age and gender of the patients wererecorded. Furthermore, surgical intervention type (spinalinstrumentation, lumbar discectomy), biopsy results of infectedtissue, concomitant morbidities, duration of hospital stay andmicroorganism growth in culture materials were evaluated inpatients. In addition, values of serum C-reactive protein (CRP)level, erythrocyte sedimentation rate (ESR), leukocyte, neutrophiland lymphocyte count which were obtained from these patients atadmission to hospital and at discharge from hospital wererecorded. Moreover, treatment costs of these patients wereexamined.Results: Nine patients (women=7, men=2) with a mean age of58±14.92 years were included in this study. All parameters ofpatients were not different in terms of surgical intervention type.However, when the patients were discharged from the hospital,their ESR and neutrophil counts decreased and lymphocyte countincreased in all of them. Although CRP level values decreased asnumerical value at discharge, this decrease was not statisticallysignificant. Correlation analysis showed that length of hospitalstay and tissue biopsy performed to the patients increased theeconomic cost.Conclusion: It was concluded that any routine laboratoryparameter investigated in this study could not be a validbiomarker for diagnosis and follow-up of spondylodiscitis thatemerged after surgical intervention. On the other hand, it wasconcluded that diagnosis and treatment of this disease, whoseprevalence is increasing, may have a high economic cost forpatients and countries.
dc.identifier.doi10.24938/kutfd.792597
dc.identifier.endpage347
dc.identifier.issn2148-9645
dc.identifier.issue3
dc.identifier.startpage341
dc.identifier.trdizinid421512
dc.identifier.urihttps://doi.org/10.24938/kutfd.792597
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/421512
dc.identifier.urihttps://hdl.handle.net/20.500.12587/23084
dc.identifier.volume22
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofKırıkkale Üniversitesi Tıp Fakültesi Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241229
dc.subjectTıbbi Araştırmalar Deneysel
dc.subjectGenel ve Dahili Tıp
dc.subjectPatoloji
dc.titleECONOMIC COST, DIAGNOSTIC AND PROGNOSTIC MARKERS IN IATROGENIC LUMBAR SPONDYLODISCITIS
dc.typeArticle

Dosyalar